KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Liabilities and Shareholders Equity (2016 - 2025)

AbbVie (ABBV) has disclosed Liabilities and Shareholders Equity for 14 consecutive years, with $134.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 0.89% to $134.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $541.2 billion, a 4.95% decrease, with the full-year FY2025 number at $134.0 billion, down 0.89% from a year prior.
  • Liabilities and Shareholders Equity was $134.0 billion for Q4 2025 at AbbVie, roughly flat from $133.9 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $150.5 billion in Q1 2021 to a low of $133.9 billion in Q3 2025.
  • A 5-year average of $140.6 billion and a median of $140.1 billion in 2022 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 65.02% in 2021, then dropped 8.54% in 2025.
  • AbbVie's Liabilities and Shareholders Equity stood at $146.5 billion in 2021, then dropped by 5.27% to $138.8 billion in 2022, then fell by 2.95% to $134.7 billion in 2023, then grew by 0.33% to $135.2 billion in 2024, then decreased by 0.89% to $134.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Liabilities and Shareholders Equity are $134.0 billion (Q4 2025), $133.9 billion (Q3 2025), and $137.2 billion (Q2 2025).